GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » L&K Biomed Co Ltd (XKRX:156100) » Definitions » Ending Cash Position

L&K Biomed Co (XKRX:156100) Ending Cash Position : ₩5,047 Mil (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is L&K Biomed Co Ending Cash Position?

L&K Biomed Co's Ending Cash Position for the quarter that ended in Dec. 2023 was ₩5,047 Mil.

L&K Biomed Co's quarterly Ending Cash Position increased from Jun. 2023 (₩2,540 Mil) to Sep. 2023 (₩4,745 Mil) and increased from Sep. 2023 (₩4,745 Mil) to Dec. 2023 (₩5,047 Mil).

L&K Biomed Co's annual Ending Cash Position declined from Dec. 2021 (₩16,108 Mil) to Dec. 2022 (₩7,395 Mil) and declined from Dec. 2022 (₩7,395 Mil) to Dec. 2023 (₩5,047 Mil).

L&K Biomed Co Ending Cash Position Historical Data

The historical data trend for L&K Biomed Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

L&K Biomed Co Ending Cash Position Chart

L&K Biomed Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 702.77 4,910.24 16,107.72 7,394.98 5,047.16

L&K Biomed Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,394.98 6,775.76 2,540.25 4,744.50 5,047.16

L&K Biomed Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

L&K Biomed Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=7394.976+-2347.818
=5,047

L&K Biomed Co's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=4744.501+302.657
=5,047

L&K Biomed Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of L&K Biomed Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

L&K Biomed Co (XKRX:156100) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » L&K Biomed Co Ltd (XKRX:156100) » Definitions » Ending Cash Position
Comparable Companies
XKRX:164060 XKRX:228850 XKRX:104540 XKRX:004080 XKRX:241820 XKRX:065510 XKRX:263690 XKRX:149980 XKRX:305090 XKRX:100700 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
17 Floor, 159-1, Mokdongseo-ro, Yangcheon-gu, Seoul, KOR
Website
http://www.lnkbiomed.com
L&K Biomed Co Ltd is a medical device manufacturer. The company develops, manufactures and markets orthopedic spinal implant of medical devices. Its products are Anterior Cervical plate, Posterior cervical fixation, and Anteiro cervical cage system.

L&K Biomed Co (XKRX:156100) Headlines

No Headlines